{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:12:24Z","timestamp":1791353544200,"version":"4.3.1"},"reference-count":21,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej15-0409","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T05:40:55Z","timestamp":1452836455000},"page":"405-410","source":"Crossref","is-referenced-by-count":18,"title":["A novel mutation in &lt;i&gt;HESX1&lt;\/i&gt; causes combined pituitary hormone deficiency without septo optic dysplasia phenotypes"],"prefix":"10.1507","volume":"63","author":[{"given":"Masaki","family":"Takagi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"},{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Children&rsquo;s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ohtsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Narumi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Romero CJ, Nesi-Fran&ccedil;a S, Radovick S (2009) The molecular basis of hypopituitarism. <i>Trends Endocrinol Metab<\/i> 20: 506-516.","DOI":"10.1016\/j.tem.2009.06.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT (2009) Genetic regulation of pituitary gland development in human and mouse. <i>Endocr Rev<\/i> 30: 790-829.","DOI":"10.1210\/er.2009-0008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pf&auml;ffle R, Klammt J (2011) Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. <i>Best Pract Res Clin Endocrinol Metab<\/i> 25: 43-60.","DOI":"10.1016\/j.beem.2010.10.014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, <i>et al<\/i>. (2012) Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. <i>J Clin Endocrinol Metab<\/i> 97: E694-E699.","DOI":"10.1210\/jc.2011-2938"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Reynaud R, Jayakody SA, Monnier C, Saveanu A, Bouligand J, <i>et al<\/i>. (2012) PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption. <i>J Clin Endocrinol Metab<\/i> 97: E1068-E1073.","DOI":"10.1210\/jc.2011-3056"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. McCabe MJ, Gaston-Massuet C, Gregory LC, Alatzoglou KS, Tziaferi V, <i>et al<\/i>. (2013) Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia. <i>J Clin Endocrinol Metab<\/i> 98: E547-E557.","DOI":"10.1210\/jc.2012-3067"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fukami M, Iso M, Sato N, Igarashi M, Seo M, <i>et al<\/i>. (2013) Submicroscopic deletion involving the fibroblast growth factor receptor 1 gene in a patient with combined pituitary hormone deficiency. <i>Endocr J<\/i> 60: 1013-1020.","DOI":"10.1507\/endocrj.EJ13-0023"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, <i>et al<\/i>. (1998) Mutations in the homeobox gene HESX1\/Hesx1 associated with septo-optic dysplasia in human and mouse. <i>Nat Genet<\/i> 19: 125-133.","DOI":"10.1038\/477"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Carvalho LR, Woods KS, Mendonca BB, Marcal N, Zamparini AL, <i>et al<\/i>. (2003) A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. <i>J Clin Invest<\/i> 112: 1192-1201.","DOI":"10.1172\/JCI18589"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, <i>et al<\/i>. (2001) Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. <i>Hum Mol Genet<\/i> 10: 39-45.","DOI":"10.1093\/hmg\/10.1.39"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tajima T, Hattorri T, Nakajima T, Okuhara K, Sato K, <i>et al<\/i>. (2003) Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. <i>J Clin Endocrinol Metab<\/i> 88: 45-50.","DOI":"10.1210\/jc.2002-020818"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. McNay DE, Turton JP, Kelberman D, Woods KS, Brauner R, <i>et al<\/i>. (2007) HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. <i>J Clin Endocrinol Metab<\/i> 92: 691-697.","DOI":"10.1210\/jc.2006-1609"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takagi M, Narumi S, Hamada R, Hasegawa Y, Hasegawa T (2014) A novel KAL1 mutation is associated with combined pituitary hormone deficiency. <i>Human Genome Variation<\/i> (in press).","DOI":"10.1038\/hgv.2014.11"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cohen RN, Cohen LE, Botero D, Yu C, Sagar A, <i>et al<\/i>. (2003) Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. <i>J Clin Endocrinol Metab<\/i> 88: 4832-4839.","DOI":"10.1210\/jc.2002-021868"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Brickman JM, Clements M, Tyrell R, McNay D, Woods K, <i>et al.<\/i> (2001) Molecular effects of novel mutations in Hesx1\/HESX1 associated with human pituitary disorders. <i>Development<\/i> 128: 5189-5199.","DOI":"10.1242\/dev.128.24.5189"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mitsui T, Narumi S, Inokuchi M, Nagasaki K, Nakazawa M, <i>et al.<\/i> (2014) Comprehensive next-generation sequencing analyses of hypoparathyroidism: identification of novel GCM2 mutations. <i>J Clin Endocrinol Metab<\/i> 99: E2421-2428.","DOI":"10.1210\/jc.2014-2174"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dasen JS, Martinez Barbera JP, Herman TS, Connell SO, Olson L, et al. (2001) Temporal regulation of a paired-like homeodomain repressor\/TLE corepressor complex and a related activator is required for pituitary organogenesis. <i>Genes Dev<\/i> 15: 3193-3207.","DOI":"10.1101\/gad.932601"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, et al. (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. <i>Nature<\/i> 384: 327-333.","DOI":"10.1038\/384327a0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Izumi Y, Suzuki E, Kanzaki S, Yatsuga S, Kinjo S,<i> et al<\/i>. (2014) Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism. <i>Fertil Steril<\/i> 102: 1130-1136.","DOI":"10.1016\/j.fertnstert.2014.06.017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. McCabe MJ, Hu Y, Gregory LC, Gaston-Massuet C, Alatzoglou KS, et al. (2015) Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD). <i>Mol Cell Endocrinol<\/i> 417: 63-72.","DOI":"10.1016\/j.mce.2015.09.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Newbern K, Natrajan N, Kim HG, Chorich LP, Halvorson LM, et al. (2013) Identification of HESX1 mutations in Kallmann syndrome. <i>Fertil Steril<\/i> 99: 1831-1837.","DOI":"10.1016\/j.fertnstert.2013.01.149"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/4\/63_EJ15-0409\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T18:45:08Z","timestamp":1654109108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/4\/63_EJ15-0409\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0409","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}